Na+/CI--dependent glycine transporters are crucial for the termination of neurotransmission at glycinergic synapses. Two different glycine transporter genes, GlyTl and GlyT2, have been described.
Several isoforms differing in their 5' ends originate from the GlyTl gene. We have determined the genomic structure of the murine Glyfl gene to elucidate the genetic basis underlying the different isoforms. Analysis of cDNA 5'-ends revealed that the GlyTla and 1 b/ lc mRNAs are transcribed from two different promoters. During murine embryonic development GlyTl mRNAs were detectable by RNase protection assays as early as embryonic day E9 and reached maximal levels between El3 and E15. In situ hybridization revealed GlyTl expression in the developing spinal cord mainly in the ventral part of the ventricular zone at E12. At later stages (E15) transcripts were also found in the lateral half of the basal and intermediate gray matter. In contrast, the second glycine transporter gene GlyTP displayed a completely different expression pattern. At El1 it is expressed in the mantle zone, and at later stages throughout the ventral horns. In the adult rat brain and spinal cord, GlyTl hybridization signals were found exclusively in glial cells. Our data indicate that GlyTl is an early marker of neural development and encodes gliaspecific transporter proteins. [Key words: g/ycine transporter, gene structure, alternate promoters, g/y&e receptor, in situ hybridization, embryonic development,
spinal cord]
Tremendous progress has been made in understanding the molecular mechanisms of synaptic transmission, and an increasing number of both pre-and postsynaptic proteins has been studied at the molecular level. With the recent cloning of several members of the Na+-/Cl--dependent neurotransmitter transporter family another important synaptic component, neurotransmitter uptake, has become amenable to functional studies. Neurotransmitter transporters are located both in the presynaptic membrane Recei ved July 13, 1994; revised Sept. 23, 1994; accepted Sept. 27, 1994 and on surrounding glial cells (for a recent review, see Schloss et al., 1994) and are crucial for the rapid removal of neurotransmitters from the synaptic cleft. This reuptake terminates synaptic transmission and helps to replenish transmitter pools in the presynaptic nerve terminal. Cloning of the transporters for GABA (Guastella et al., 1990 ) and norepinephrine (Pacholczyck et al., 1991) allowed the subsequent isolation of a number of cDNAs encoding homologous Na+/Cll-dependent transporters, including those for dopamine (Giros et al., 1991; Kilty et al., 1991; Shimada et al., 1991; Usdin et al., 1991) , 5-HT Hoffman et al., 1991) , and glycine (Guastella et al., 1992; Liu et al., 1992b; Smith et al., 1992) . All these transporters share a postulated structure of 12 transmembrane domains deduced from hydropathy plots (Guastella et al., 1992; Smith et al., 1992) . Several neurotransmitter uptake systems display an unexpected molecular heterogeneity as shown by the cloning of four different GABA (Lopez-Corcuera et al., 1992; Liu et al., 1993a) and glytine (Borowsky et al., 1993; Liu et al, 1993b; Kim et al., 1994) transporter cDNAs. Three of the latter (GlyTla, lb, and lc) are encoded by a single gene and differ only in their amino-terminal region (Kim et al., 1994) . The fourth transporter GlyT2 is generated from a separate gene with 48% amino acid sequence identity to GlyTl and is pharmacological distinguishable from the different GlyTl isoforms (Liu et al., 1993b) .
The expression of GlyTla and GlyTlb in adult rats and mice has been studied by in situ hybridization (Guastella et al., 1992; Liu et al., 1992b; Smith et al., 1992; Borowsky et al., 1993) . Both variants are expressed in many regions of the CNS including hypothalamus, mesencephalon, brainstem, and spinal cord. GlyTl a mRNA is present in regions with a high density of neuronal cell bodies and was proposed to colocalize with inhibitory glycine receptor subunit mRNA (Borowsky et al., 1993) . In addition GlyTla is expressed in several peripheral tissues, for example, liver, lung, and stomach. In contrast, in brain the GlyTlb mRNA was suggested to colocalize with the NMDA subtype of glutamate receptors (Smith et al., 1992) . Glycine transporters might modulate the concentration of glycine at its coagonist binding site on the NMDA receptor (Johnson et al., 1987; Kuryatow et al., 1994) by uptake into neighboring glial cells or by reverse transporter-mediated release (Attwell et al., 1992 (Attwell et al., , 1993 , and thereby affect the efficacy of glutaminergic synapses. The GlyT2 mRNA was found to be restricted to the central nervous system and to be mainly localized in spinal cord and brainstem (Liu et al., 1993b) , which correlates well with the distribution of inhibitory, strychnine-sensitive glycine receptors (Betz, 1992) .
To further understand the roles of the different GlyTl isoforms in glycinergic and glutaminergic neurotransmission we analyzed both the genomic structure and the developmental and regional expression of the murine GlyTl gene. Our data show that two isoforms, GlyTla and lb, originate from transcription initiated at alternate promoters, whereas GlyTlc is a splice variant of the 1 b transcript. In situ hybridization revealed that in the CNS GlyTl transcripts are expressed in glial cells.
Materials and Methods
Isolation of the GLYTI cDNA. We screened 1.6 X lo6 pfu of a mouse brain cDNA library (Stratagene, Heidelberg, Germany) with a 740 bp PCR fragment (Glyt740 probe; see Table l) , and a single hybridizationpositive clone was isolated. Partial sequencing showed that the cDNA sequence was identical to that published by Liu et al. (1992b) . Full-length cDNA 5'.ends were isolated by using the 5'-RACE Ready cDNA kit (Clontech, Palo Alto, CA). Two subsequent PCR amplifications were performed with the supplied anchor primer (sense) and different combinations of nested gene-specific primers (antisense) 5'. CCATCATACCATAGCCCACG-3' (exon 4), 5'-GAAGATCAGCATG-ATGAAGTA-3' (exon 3), 5'-GTGTGAGGTTCTGGTCCTTC-3' (primer G, exon 2), 5'-CTGTTCTGGGGAAGGGGTGGC-3' (primer F, exon 1 b) according to the manufacturer's specifications. The fragments obtained were subcloned into Bluescript (Stratagene, Heidelberg, Germany) and sequenced.
Isolation and analysis of genomic clones. The GlyTl cDNA was labeled with digoxigenin-11-dUTP (DIG DNA labeling and detection kit, Boehringer Mannheim, Mannheim, Germany) and used for screening a mouse genomic library constructed in the vector XFIX (Stratagene, Heidelberg, Germany) following standard protocols (Sambrook et al., 1989) . In addition three overlaoning genomic Pl clones (Pl #605, #606, #607) in the vector pADlOsa&I w&e obtained by a PCR screen performed by Genome Systems (St. Louis, MO; primers used: sense 5'-CTTCGGCCAGTTTGCAAGCC-3', antisense 5'-CCATCATACCA-TAGCCCACG-3'; see Table 1 ). A genomic map comprising 18 kb of the GlyTl gene was generated by sequencing of selected genomic subclones, PCR and restriction mapping of clone AGMGTl (Cosmid mapping kit, Takara, Kyoto, Japan). Genomic DNA fragments were sequenced after subcloning into Bluescript using a T7 DNA sequencing kit (Pharmacia, Freiburg, Germany) and synthetic oligonucleotide primers. Computer analysis was done using the HUSAR 3.0 software (Deutsches Krebsforschungszentrum, Heidelberg, Germany).
Polymerase chain reaction and recombinant DNA. Probes for cDNA screening and in situ hybridization were generated by amplifying DNA fragments from rat brain cDNA (GLYTl: Glyt740 probe, sense 5'-GGTATGATGGTGGTGTCCACGTAC-3', antisense 5'-GACACA-TCCACACCCAGGTGATTG-3') by 30 cycles of denaturation (45 set, 94"C), annealing (45 set, 65°C) and extension (1 min, 72"(Z), 50 ng of mouse genomic DNA (300 hp GlyRal: sense 5'-GGAGAATTCTT-CAGGATGATGAGGGTGG-3', antisense 5 '-GGGGATCCAGCClT-CACTTGTTGTGGAC-3': 300 bo GlvRa2: sense: 5'-CCCTTTGCATGGTGATGcicG-3', antisense: '5 r-GITCACTAGCTGCCGGTACA-3'; 340 bp GlyRB: sense 5'-GCGGATCCCATAATTGCTGATCTGTG-3', antisense: 5'-GGGATTCGATACTGCATACATGGAC-3') by 30 cycles of denaturation (1 min, 94"C), annealing (I 5 min, 60°C) and extension (1.5 min, 72"C), or mouse brain cDNA (300 bp GlyT2: sense 5'-GGGGATCCCACAGGGTGGAATCTACATG-7, antisense 5 '-GGGAATTCGCATCAGCCATCCAAGCACC-3') by 30 cycles of denaturation (1 min, 94"C), annealing (1.5 min, 55°C) and extension (1.5 min, 72°C).
PCR analysis of GlyTl cDNA 5'-ends was done with primers A 5'-
(antisense), and G 5'-GTGTGAGGTTCTGGTCCT-TC-3' (antisense) by 30 cycles of denaturation (1 min, 94"C), annealing
(1 min, 58°C) and extension (2 min, 72°C). The following products were obtained: primers A and C, 420 hp; B and C, 360 bp; A and G, 510 bp; and E and E 230 bp. The fragments were cloned into Bluescript, and the identity of the clones was verified by dideoxy sequencing. PolyA+ RNA was purified using the polyATract system (Promega, Heidelberg, Germany). cDNA was prepared from 1 p,g of adult rat or mouse brain polyA+ RNA using a cDNA synthesis kit (Boehringer Mannheim, Mannheim, Germany) in a final volume of 20 p,l according to the manufacturer's specifications. Aliquots of the cDNA (1 t.~l) were used for PCR reactions.
A 1.9 kb NcoI-BsaBI fragment containing most of the GlyTla cDNA was cloned into Bluescript (Stratagene, Heidelberg, Germany) and used for in situ hybridization (probe GlyTla/b). Probe GlyTla was generated from a 210 bp EcoRI-BglII fragment of the GlyTla cDNA and probe GlyTlb from a 253 bp PCR fragment generated from genomic DNA corresponding to primers: 5'-CCCTCGCTGGGCTGCATCAG-3' (sense), 5'-CTGTTCTGGGGAAGGGGTGGC-3' (antisense). A 450 bp BgIII-BsaAI fragment of the GlyTl cDNA was used as a template to generate antisense RNA for RNase protection assays. A 258 bp BamHISac11 fragment from the mouse B-tubulin 5 gene (BTub5, generously provided by R. Balling) was used as internal control in RNase protection assays. All GlyTl-specific probes are listed in Table 1. RNA isolation ana' analysis.
Mouse embryos were obtained from NMRI mice (Zentralinstitut ftir Versuchstierzucht, Hannover, Germany). Mice were mated overnight, and the day of detection of vaginal plugs was designated embryonic day zero (EO). Total RNA was prepared from embryos or tissues using the guanidine thiocyanate method (Chirgwin et al., 1979) . RNase protection assays were performed as described previously (Ptischel at al., 1990) ; 100 p,g of total RNA were used for the hybridization with 6 X lo6 cpm of GlyTla, and 1 X lo6 cpm of BTubS, antisense RNAs, respectively. In situ hybridization of paraffin embedded embryos (10 pm sections) with 75S-labeled RNA probes was done as described (Ptischel et al., 1992) . RNA probes were generated by in vitro transcription of subcloned cDNA fragments using T3 or T7 RNA polymerase (New England Biolabs, SchwalbacluTaunus, Germany). The antisense RNAs were labeled by the incorporation of OL-~~S-LJTP (30 TBq/ mmol, Amersham Buchler, Braunschweig, Germany) for in situ hybridization experiments, or of c$~P-UTP (37-110 lBq/mmol, Amersham Buchler, Braunschweig, Germany) for RNase protection assays.
Northern blotting was performed as described recently (Piischel et al., 1994) , using a 0.9 kb BglII fragment from the Glytla cDNA (Liu et al., 1992b ; Table 1 ) labeled with 32P as a probe.
In situ hybridization analysis of GlyTl expression in adult rat brain was done as described previously (Sato et al., 1993) using 'S-labeled antisense oligonucleotides complementary to bases 536-580 or to of the rat GlyTlb cDNA (Smith et al., 1992) .
Results
Structure of the murine GlyTl gene In order to understand the genetic origin of the various GlyTl isoforms we determined the structure of the corresponding
gene. An initial screen of a mouse genomic XFIX library with the GlyTl cDNA yielded only a single clone containing exons lb-4. To obtain additional sequences a genomic Pl-library was screened by PCR, and three overlapping clones were isolated. The structure of the GlyTl gene was determined by sequencing subclones of the Pl-inserts ( Fig. 1A ) with primers derived from the published mouse GlyTl cDNA sequence.
The coding sequence of the murine GlyTl gene is divided into 13 exons distributed over a region of 18 kb ( Fig. lA) , with most of the coding exons being clustered (exons 2-13) within 7 kb. In contrast, the exons encoding the alternative amino-terminal ends of the GlyTl proteins are separated by larger introns. The size of the introns in the GlyTl gene and the sequences of the exon-intron junctions are listed in Table 2 . The intron-exon structure of the GlyTl gene is very similar to that of the GABA transporter gene, GATl (Liu et al., 1992a) . With few exceptions, homologous sequences are encoded by exons of identical size in both genes. The sequences corresponding to exons 4 and 8 of GlyTl are split into two exons in GATl. The position of the intron-exon junction separating exons 6 and 7 of GlyTl differs by 8 bp in the GATl gene, suggesting that this site might have evolved independently in both genes after duplication of a common precursor. Finally, the sequences and the genomic organization of the GlyTl 5'-ends (exons Oa, la, lb, lc) are very different from the corresponding regions of GATl. The schematic representation of the putative transmembrane topology of GlyTl (Fig. 1C) illustrates that most of the transmembrane regions of the protein are encoded by a single exon. This is consistent with the observation that individual exons often correspond to structural units of the encoded protein (Dorit (Liu et al., 1992b ) is shown. Base pairs 1-14 of the cDNA (Liu et al., 1992b) et al., 1990) . The only exception from this rule is exon 8, which encodes two putative transmembrane domains. Interestingly, in the GATl gene the corresponding region is split by an additional intron, which separates these transmembrane regions.
Analysis of GlyTl cDNA 5'-ends and identification of two separate promoters
To understand the mechanism generating the different 5'-ends of the GlyTl mRNAs, rapid amplification of cDNA 5'-ends (RACE) was performed. After two rounds of amplification with nested primers we obtained two major bands from PCR reactions with a primer common for GlyTla and lb and a single band with a GlyTlb-specific primer (data not shown). Subcloning and sequencing of these products revealed that the noncoding sequences at the 5'-ends of the la and lb/lc isoforms are completely different, and that they do not share any common exons in addition to exons 2-13 (Fig. 2) . The GlyTla mRNA is generated by splicing the 5'-specific exons Oa, la to the common exons 2-13, whereas the 5'-end of the GlyTlb transcript is con- Figure  1A . Exon sequences are typed i n uppercase letters, and intron sequences i n lowercase letters. The 5'-junction sequence of exon lc i n mouse has not been identified, because its 5' end lacks homology to the human counterpart (Kim et al., 1994) . Wi th one exception all splice sites (boldface) follow the "GTI AG"
rule; an unusual GC at the beginning of the 5'.donor splice site has been reported (Amin et al., 1993) .
tained in a single exon (lb). The third isoform GlyTlc is generated by alternative splicing of a common lb pre-mRNA (Fig.  1B) . Exons lb and lc have been reported to precede the common part of the GlyTl mRNAs encoded by exons 2-13 in humans (Kim et al., 1994) . A putative exon lc revealing 73% amino acid identity and 78% homology to its human counterpart was present in the subclones sequenced (Fig. 2) . However, only 120 bp showed a clear homology to the human sequences. No sequences homologous to the remaining 36 bp could be identified. We obtained several clones with different St-ends, some of which contained an additional 5'-terminal G residue not present in the genomic sequence. This is a typical artefact generated by reverse transcription of the 5'-cap-G structure (Hirzmann et al., 1993) , and thus allows an unambiguous identification of transcriptional startpoints. By this approach at least four different startpoints were identified from the sequence of 23 clones for GlyTlb (Fig. 2) , but a much larger number of startpoints probably exists as indicated by the high diversity of RACE products. Eight clones specific for GlyTla were sequenced, but a similar variety of 5' ends was observed (see Fig. 2 caption) . Additional sequences included in the GlyTla mRNA population were identified by PCR of mouse brain cDNA with different sense primers derived from the genomic sequence (Fig. 2) . In conclusion, our sequence data prove that the mRNA isoforms GlyTla and lb/ lc originate from initiation of transcription from different promoters, and that startpoints for both primary transcripts are scattered over a region of about 150 bp. It remains unclear why only a single band for all GlyTl mRNA isoforms was observed in Northern hybridization experiments (Borowsky et al., 1993; Kim et al., 1994) , whereas differences in size of about 350 bp would be expected from our analysis of cDNA 5'-ends.
Analysis of the regions upstream of the GlyT 1 a and GlyT 1 b transcription startpoints identified high GC contents (60%) and several potential Spl binding sites (Jones et al., 1985) preceding exon Oa.
Expression of GlyTl mRNAs during embryonic development Expression of the murine GlyTl gene during embryonic development was analyzed by a RNase protection assay. A 450 bp fragment corresponding to sequences from exons Oa, la, and 2-5 of the GlyTla cDNA clone (Fig. 3A) was used as a template to synthesize a 33P-labeled antisense RNA probe. A 258 bp fragment of the P-tubulin 5 cDNA (Wang et al., 1986 ; provided by R. Balling) was used in addition as an internal control for comparable RNA amounts. A mixture of both probes was annealed with total RNA isolated from E9 to El7 mouse embryos, and with RNA from adult mouse brain and liver (Fig. 3B) . A fragment corresponding to the expected length of the GlyTla sequence was detected in every sample with the exception of the yeast control RNA. In addition a shorter fragment corresponding in length to the sequence shared by all variants was observed; this fragment corresponds to the Glytlb/c mRNA protected sequence. Weak signals for GlyTla and the GlyTlb/c variants were observed even at the earliest stages of embryonic development analyzed (E9, ElO). Maximal levels of GlyTl transcripts were found at embryonic stages El3 to E15. Both protected fragments were also obtained with adult brain and liver RNA. The latter result is in disagreement to a Northern blot analysis published by Borowsky et al. (1993) , who found GlyTlb mRNAs only in the CNS. Our results were corroborated by Northern blot hybridization which showed strong expression only in brain and liver and weak expression in lung and kidney (Fig. 3C) .
Distribution of glycine transporter GlyTl and GlyT2 mRNAs
The spatial pattern of GlyTl expression in the developing mouse embryo was analyzed by in situ hybridization with 35S-labeled antisense RNA probes and compared to that of GlyT2, and the inhibitory glycine receptor subunit genes GlyRa 1, GlyRa2, and GlyRP. Three different probes for GlyTl were tested. The best results were obtained with probe GlyTla/b which encompasses the complete coding sequence of GlyTl and detects all variants. Probes specific for GlyTla or GlyTl b gave no signal above background, presumably because of their relatively small size.
GlyTl mRNAs were first detected in the spinal cord at El 1 in the ventral part of the ventricular zone which contains the proliferating precursors of neurons and glia (Fig. 4A) . At El2 the GlyTl signal in the ventricular zone was more pronounced Figure 2 . Analysis of GlyTl cDNA 5'-ends and identification of two separate promoters. The structures of exons la, lb, and 2 as proposed by Liu et al. (1993b) and the 5'-end of the GlyTla cDNA (exon Oa; see Liu et al., 1992b) are indicated in uppercase (exons) and lowercase (introns) letters. Only a partial sequence of a putative exon (lc) homologous to the human GlyTlc (Rim et al., 1994 ) is shown in uppercase. The 5' end of the mouse sequence could not be identified by comparison to its human counterpart. Different 5'-ends of clones generated by RACE experiments indicate the existence of several startpoints of transcription. The most 5'.located initiation sites including those containing an uncoded 5'-terminal G residue caused by reverse transcription of the 5'-cap-G structure (marked by ICAP) are indicated by thick arrows. Multiple startpoints of transcription preceding exon lb prove that the GlyTla and lb isoforms originate from two separate promoters. A potential splice junction in front of exon lb predicted by computer analysis (Liu et al., 1993b) appears not to be used, since PCR of randomly primed cDNA with primers D and F (marked by arrows above the sequence) yielded no product. In contrast, a specific product was obtained with primers E and E although the sense primer shows only a partial overlap with the longest RACE clone analyzed. PCR analysis with primers A or B (sense) and C (antisense) gave specific products and additional sequence information about the 5' ends of the GlyTla mRNA. In contrast, a sense primer positioned 150 bp upstream from primer A for PCR, yielded no product. Only GlyTla-specific products resulted from PCR with primers A (or B) and G, and Southern hybridization (data not shown) failed to detect GlyTlb-specific product from this reaction. This demonstrates that no splice product of exons Oa and lb is generated. An unexpected RACE clone amplified with the anchor primer and primer G included 87 bp of the intronic sequence upstream of exon 2 at its 5'-end (marked by as&n'&) and probably reflects aberrant splicing. In our analysis, no clones corresponding to the GlyTlc variant were obtained.
( Fig. 4B) . At El5 GlyTl transcripts were also detected in the Expression of GlyT2 was detected as early as El1 in the inadjacent ventral mantle zone and the meninges surrounding the termediate position of the mantle zone directly adjacent to the spinal cord (Fig. 1C) . A strong signal for GlyTl was also obventricular zone (Fig. 40) . At El2 expression in this region was tained in liver in sagittal sections of El2 and El5 embryos (data still visible, but additional signals were observed in the basal not shown), consistent with data showing GlyTla expression in and alar plates (Fig. 4E ). These regions do not express GlyTl, adult liver (Borowsky et al., 1993) . Other embryonic tissues did but contain postmitotic neural precursors. At El5 GlyT2 trannot show significant hybridization signals.
scripts were seen preferentially in the ventral horn of the gray Figure 3 . Accumulation of GlyTl transcripts in the developing mouse embryo and distribution in several tissues of adult rats. A, Schematic representation of the products (solid bars) generated by RNase protection of an GlyTla-specific antisense RNA probe with GlyTla or lb/lc mRNAs. Exons are indicated by numbered boxes. &Total RNA isolated from whole embryos at different embryonic stages (E9-E16), from heads or trunks at days El7 and PO, and from adult brain or liver, was analyzed by RNase protection assay using 33P-labeled probes for the GlyTla (450 bases) and B-tubulin 5 (BTub5, 258 bases) mRNAs. Bands corresponding to the transcripts (arrows) GlyTla and Ib/lc were observed as early as E9 and reached maximal levels between El3 and E15. Additionally both mRNAs were detectable in adult brain and liver, but not in a control sample (yeast total RNA). The presence of similar amounts of RNA in all samples was demonstrated by the product obtained with the BTub5 probe. Sizes of DNA marker fragments (Boehringer Mannheim) are 653, 517, 453, 394, and 298 bp. C, Distribution of GlyTl mRNAs in several tissues of adult rats. PolyA+ RNA from brain, kidney, heart, muscle, lung, and liver was hybridized with a probe recognizing all Glytl mRNA variants. Strong signals of about 3.2 kilobases were obtained for brain and liver, whereas a weak band of the same size was visible for lung. Transcript size is indicated in kilobases. matter (Fig. 4F) , with lower levels in intermediate layers and absent from the dorsal horn.
To compare the sites of glycine transporter expression to regions synthesizing the postsynaptic glycine receptors we also hybridized embryonic sections to probes specific for different glycine receptor subunits. GlyRa2 is the first glycine receptor subunit to be expressed during embryonic development (Kuhse et al., 1990; Malosio et al., 1991; Sato et al., 1992) . Here transcripts were seen first at El2 in the lateral parts of the ventral horn, where motor neurons are located (Fig. 4H) . At El5 GlyRol2 transcripts were seen predominantly in the ventral horn, with some expression in more dorsal layers (Fig. 4H) ; this pattern resembles that seen with the GlyT2 probe. In agreement with earlier reports (Malosio et al., 1991) expression of the GlyRcxl and GlyRP mRNA was detectable throughout the gray matter in El5 spinal cord, but not at earlier stages (data not shown). Low levels of GlyRB mRNA were in addition seen in dorsal root ganglia (data not shown).
GlyTl is expressed in glial cells
To more precisely determine the cell types expressing GlyTl we performed in situ hybridization with sections of adult rat brain and spinal cord, which allow an easier identification of cell types according to morphological and anatomical criteria. By using two GlyTl-specific antisense oligonucleotide probes derived from the rat GlyTla cDNA (Smith et al., 1992) , the regional expression of GlyTl mRNAs was investigated. In general, positive cells were distributed throughout the CNS and detectable in both gray and white matter (Fig. 5A, C,E, G) . In the gray matter cells containing GlyTl transcripts were small-sized and neurons were devoid of hybridization signals (Fig. 5B) , suggesting that the positive cells are of glial origin.
In the spinal cord (Fig. 5A ) positive cells were observed not only in the gray, but also in the white matter. At higher magnification hybridization signals were mainly seen over small-sized cells surrounding motor neurons, whereas neurons did not show any signal (Fig. 5B) . In the cerebellum expression of GlyTl was mainly observed in the white matter and in the Purkinje cell layer (Fig. 5C ). Silver grains were absent over Furkinje cell bodies (Fig.  5D ) but many small cells surrounding the Purkinje cells exhibited strong hybridization signals. From their anatomical appearance the positive cells are likely to be Bergmann glia, a specialized class of astrocytes. The level of GlyTl expression in hippocampus and cerebral cortex (Fig. 5&F) is relatively low in contrast to the corpus callosum, which contains a large number of strongly labeled cells. However, both regions showed small-sized positive cells expressing GlyTl mRNAs at low levels. Granule cells in the dentate gyms and pyramidal cells in the Ammon's horn did not express GlyTl transcripts but many small labeled cells were observed throughout the hippocampus. The optic nerve also contained a large number of strongly labeled cells (Fig. 5G,H) . Since there are no neuronal cell bodies in this structure, it is obvious that glial cells express the GlyTl mRNAs. Discussion Genomic structure of the glycine transporter I gene and generation of mRNA variants We determined the genomic structure of the GlyTl gene in order to understand the origin of the different transporter isoforms and the genetic basis of their regulation. The genomic organization of the GlyTl gene is very similar to that of GATl (Liu et al., 1992a) . It has been hypothesized that the transmembrane regions, which are highly conserved among different members of the transporter family, form a "core" transporter, whereas the extra-and intracellular loops as well as the amino-and carboxy-terminal regions are responsible for specific properties, such as substrate selectivity and regulation (Clark et al., 1992; Fremeau et al., 1992; Mabjeesh et al., 1992) . This seems to be reflected in the genomic structure of the GlyTl and GATl genes (Liu et al., 1992a) . In both genes most transmembrane segments are encoded by single exons, and most splice site positions and sequences are highly conserved. The only exceptions are transmembrane segments 7 and 8 of GlyTl which are encoded by a single exon but by separate exons in the GATl gene. In addition, the coding sequence of the second large extracellular loop in GATl is divided into two exons in contrast to the single exon 4 that encodes the corresponding sequence in GlyTl. Interestingly, the amino acid sequence of the first half of this loop is highly conserved between both transporters, whereas the second part, which is encoded by a separate exon in GATl, strongly differs in its length and sequence. In contrast to the transmembrane segments, the sequences of the amino-and carboxy-terminal ends, encoded by exons I and 13, of GlyTl show very little homology to GATl. Also, the sequence variants for the amino terminus of GlyTl are unrelated to GATl. Accordingly, the genomic structure of the 5'-ends of both genes differs greatly.
So far it remained unclear whether different GlyTl isoforms arise from the use of different promoters or by alternative splicing of a common pre-mRNA. Our data clearly demonstrate that the mRNAs for the two variants GlyTla and lb are generated from two different promoters in from of exons Oa and 1 b, and that both promoters use multiple transcriptional startpoints and lack TATAboxes. Multiple startpoints of transcription have been reported for many genes lacking TATA-boxes (Harlan et al., 1991; Ma et al., 1992) and, together with a high GC content (60% in the GlyTl gene), are characteristic for promoters of many housekeeping genes (Smale et al., 1989; Harlan et al., 1991) . Analysis of the two promoters in the GlyTl gene should reveal genetic elements responsible for the differential expression of the isoforms.
Expression of glycine transporters and glycine receptor subunits in the developing embryonic spinal cord of mouse
The mRNAs for the glycine transporter variants GlyTla and lb/ lc are present at low levels as early as E9 and El0 as determined by RNase protection assays, but strongly increase at stage El3 and remain at high levels up to E15. As the RNase protection assays were done with RNA from whole embryos, these results do not provide a spatial resolution. Therefore, the distribution of GlyTl and GlyT2 transcripts in the developing mouse spinal cord 'was analyzed by in situ hybridization. Consistent with the time course of expression shown by RNase protection assays, specific mRNAs could be detected at early stages. Strong signals with both GlyTl and GlyT2 probes are first seen at El 1 in nonoverlapping domains. The expression of glycine transporter genes and GlyRo2 (see below) is activated much earlier than formation of synapses in the spinal cord has been observed (Vaughn et al., 1973; May et al., 1975) , indicating that ceils generating a glycinergic synapse possess a neurochemical identity early in development. The expression of GlyTl is limited to the ventral part of the ventricular zone, which contains precursors of neurons and glial cells (Nomes et al., 1974 (Nomes et al., , 1978 . GlyT2 expression was observed at an intermediate position in the mantle zone. At El2 the GlyTl expression domain is unchanged, but GlyT2 transcripts are more widely distributed with the highest levels in the medial part of the mantle zone. Thus, at this stage GlyTl mRNAs are found exclusively in proliferating cells, whereas the message for GlyT2 is limited to postmitotic cells (Altman et al., 1984) . The expression domains start to overlap only at E15. Now, signals specific for GlyTl increased in the ventral part of the ventricular zone and in addition were detected in the medial half of the basal and intermediate gray matter. GlyT2 is expressed preferentially throughout the ventral horns and excluded from the dorsal horn at this stage. The expression pattern of GlyTl at El5 is similar to genes expressed specifically in glia , whereas that of GlyT2 is more reminiscent of a neuronal expression. Motor neurons receive inhibitory glycinergic innervation from spinal cord interneurons, which should express glycine transporters. GlyT2 transcripts are found in regions containing more ventrally located commissural interneurons and association interneurons. GlyTl expression is also seen in the meninges at E1.5, indicating that the latter might be involved in a more general control of glycine concentration in the CNS.
Glycine is the major inhibitory neurotransmitter in spinal cord, brain stem and other areas of the lower neuraxis of mam- A, Positive cells were detectable throughout the gray and the white matter. B, A motor neuron (mn) was devoid of a hybridization signal, but many small-sized positive cells displayed strong hybridization (arrows). 6, Expression of GlyTl in the cerebellum was mainly observed in the white matter and in the Purkinje cell layer (pu). D, Bergmann glia cells (thick arrow) adjacent to Purkinje cells (pu, thin arrow) showed intense hybridization. E, Note strong expression of GlyTl mRNAs in the coruus callosum (cc). F, Granule cells in the dentate gyms (gr) were de;oid of signals,'in'contrast to many small-sized cells in the polymorphic layer (PO). G, High levels of GlyTl mRNAs were detected in the optic nerve. H, Many cells in the optic nerve were labeled (arrows).
dh and vh, dorsal and ventral horn of spinal cord; gr, granule cell layer of cerebellum (C, D), and stratum granulare of the dentate avrus (F): mo. molecular laver of cerebellum; CAI-2, fields CAl-2 gi Ammdn's horn; co, cortex: Scale bar: A, 800 pm; B and F, 32 pm; C and E, 200 pm; H, 20 ym. mals (Aprison et al., 1990) . Glycine-mediated inhibition of neuronal activity results from activation of the inhibitory glycine receptor (GlyR), a ligand gated chloride channel. The GlyR is thought to be a pentamer composed of ligand binding a-subunits and structural B-subunits. Several developmentally regulated (Y subunit variants have been described which correspond to neonatal (~2) and adult (al, 013) GlyR isoforms (Betz, 1992) . Expression of the (~2 and B GlyR subunits has been found as early as El4 in rat (Malosio et al., 1991) . Here we analyzed the expression of these subunits in mouse embryos starting at El1 to identify the earliest time when the embryonal nervous system activates these genes. We first detected expression of GlyRo2 at The Journal of Neuroscience, March 1995 , 75(3) 2531 El2 which is about l-2 d earlier than described previously (Malosio et al., 1991) . Expression was seen in a small population of cells at a ventrolateral position where motor neurons are located. At this stage none of the other subunit genes was expressed. At El5 transcripts of all GlyR subunits analyzed were found. GlyRoll and B mRNAs were uniformly distributed in the spinal cord, whereas GlyRo2 transcripts were found predominantly in the ventral horn, suggesting their localization in motor neurons. Consistent with an earlier study (Furuyama et al., 1992) , GlyRB mRNA was also seen at low levels in dorsal root ganglia.
The glycine transporter GlyTl is expressed in glial cells
The distribution of GlyTl mRNA in different tissues has been investigated by several groups both by Northern blot analysis and in situ hybridization (Guastella et al., 1992; Smith et al., 1992; Borowsky et al., 1993; Kim et al., 1994) . Unfortunately, the results of these studies are contradictory. Whereas Kim et al. (1994) reported expression in all non-neuronal tissues analyzed, including kidney and liver, Liu et al. (1993) , Guastella et al. (1992) , and Smith et al. (1992) failed to detect significant amounts of GlyTl mRNA in liver. Our data show strong expression of GlyTl in liver both by an RNase protection assay and by Northern blots (Fig. 3C ). These discrepancies might be due to the different probes and hybridization conditions used. Smith et al. (1992) and Borowsky et al. (1993) reported strong to moderate expression in the pyramidal cell layer of the CAl-3 and the granule cell layer of the dentate gyrus in the hippocampus, while Guastella et al. (1992) found no hybridization in this region. Furthermore, Borowsky et al. observed strong signals in all fiber tracts, while the other two articles reported no expression. These discrepancies could be due to nonstringent hybridization conditions as well as low-resolution autoradiography. Here, we investigated the expression of GlyTl mRNA at the cellular level by using rat brain sections. Many positive cells were observed not only in the gray but also in the white matter. Usually the labeled cells were of small size and showed a similar appearance in both regions. All neurons seemed to be devoid of labeling throughout the CNS regions analyzed. For example, in the hippocampus neither pyramidal cells in the CAl-3 nor granule cells in the dentate gyrus showed positive hybridization signals. Furthermore, in the cerebellar cortex only glial cells showed strong expression. Borowsky et al. (1993) reported that GlyTla mRNA was mainly expressed in white matter, whereas GlyTlb mRNA was abundant in gray matter. These authors therefore suggested that GlyTla may be a neuronal and GlyTlb a glial glycine transporter. However, our probes, although they recognized all GlyTl mRNA isoforms, failed to reveal positive neurons throughout the CNS. Thus, we conclude that both GlyTla and GlyTlb/lc are mainly or exclusively expressed in glial cells. However, our data cannot exclude expression of GlyTl by a subpopulation of neurons or in tissues not analyzed in this study. The previously published data are consistent with the view that glial cells in the white matter express mainly GlyTla and glial cells in the gray matter mainly GlyTlb, respectively.
Note added in proof
The nucleotide sequence data in this article will appear in the EMBL, GenBank, and DDBJ Nucleotide Sequence Databases under accession numbers X82566-X82572.
